MariMed Inc.
MRMD
$0.07
$0.000.14%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.29% | 1.28% | -0.40% | 0.63% | 3.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.29% | 1.28% | -0.40% | 0.63% | 3.77% |
| Cost of Revenue | 7.13% | 7.20% | 7.42% | 9.00% | 13.28% |
| Gross Profit | -5.31% | -7.69% | -10.88% | -10.33% | -8.31% |
| SG&A Expenses | -2.06% | 2.00% | -1.10% | 2.30% | 9.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.59% | 5.21% | 4.02% | 6.34% | 11.90% |
| Operating Income | -223.84% | -158.06% | -88.08% | -90.47% | -92.39% |
| Income Before Tax | -30.16% | -166.69% | 34.96% | 29.90% | 11.90% |
| Income Tax Expenses | -63.29% | -55.95% | 201.85% | 21.23% | 8.04% |
| Earnings from Continuing Operations | 22.92% | -17.61% | -27.70% | 7.71% | 1.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 77.78% | 24.32% | 35.94% | -31.58% | -28.57% |
| Net Income | 23.13% | -17.48% | -27.41% | 7.62% | 1.49% |
| EBIT | -223.84% | -158.06% | -88.08% | -90.47% | -92.39% |
| EBITDA | -11.83% | -34.40% | -28.19% | -33.92% | -40.94% |
| EPS Basic | 25.75% | -14.60% | -25.07% | 9.29% | 3.36% |
| Normalized Basic EPS | -37.62% | -216.33% | -1,800.00% | -559.09% | -290.57% |
| EPS Diluted | 18.79% | -22.36% | -31.73% | 9.29% | 3.36% |
| Normalized Diluted EPS | -37.62% | -216.33% | -1,800.00% | -559.09% | -290.57% |
| Average Basic Shares Outstanding | 3.37% | 2.89% | 2.32% | 2.03% | 2.58% |
| Average Diluted Shares Outstanding | 3.37% | 2.89% | 2.32% | 2.03% | 2.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -0.10% | -0.01% | 0.64% | 0.66% |